2021 annual financial data

Enliven Therapeutics 2021 Operating margin

Direct answer

Operating margin was Not calculable.

Operating income was -24.76M USD and net income was -24.74M USD.
Operating cash flow was -19.13M USD.

Get free Enliven Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
0 USD
Operating income
-24.76M USD
Net income
-24.74M USD
Operating cash flow
-19.13M USD